Literature DB >> 266595

HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians.

M A Khan, W E Braun, I Kushner, D E Grecek, W A Muir, A G Steinberg.   

Abstract

Twenty-eight HLA alleles of the A and B loci were determined in 23 American Blacks and 50 Caucasians with primary ankylosing spondylitis (AS). The prevalence of HLA B27 was significantly increased in American Black patients (48 per cent) vs Black controls (two per cent), but was much less than the 94 per cent found in Caucasian patients (controls eight per cent). The lower prevalence of B27 in American Black patients vs Caucasian patients was significant (p less than 0.001), and indicated that susceptibility to AS is not as closely associated with B27 in Blacks as in Caucasians. No other HLA antigen was significantly associated with AS in either racial group. Among B27 positive individuals, the relative risk of developing AS was significantly lower in American Blacks than in Caucasians. These data indicate that for diagnostic purposes, the absence of B27 is less important in ruling out AS in Blacks than in Caucasians.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266595

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  11 in total

1.  Immunogenetic markers in rheumatic diseases.

Authors:  L Martin; M J Fritzler
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

Review 2.  Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders.

Authors:  Laura J Kopplin; George Mount; Eric B Suhler
Journal:  Ocul Immunol Inflamm       Date:  2016-05-27       Impact factor: 3.070

Review 3.  B27 positive diseases versus B27 negative diseases.

Authors:  A Linssen; T E Feltkamp
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103

Review 4.  Geoepidemiology of autoimmune rheumatic diseases.

Authors:  Yinon Shapira; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2010-06-22       Impact factor: 20.543

Review 5.  Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Authors:  Chandra Mohan; Shervin Assassi
Journal:  BMJ       Date:  2015-11-26

6.  Sacroiliitis and HLA. A clinical and genetical study.

Authors:  N Migone; V Modena; V Daneo; A O Carbonara; R Ceppellini
Journal:  Ann Rheum Dis       Date:  1978-12       Impact factor: 19.103

7.  Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan.

Authors:  James Cheng-Chung Wei; Ruey-Hong Wong; Jun-Huang Huang; Chen-Tung Yu; Chung-Tei Chou; Ming-Shiou Jan; Gregory J Tsay; Ming-Chih Chou; Hong-Shen Lee
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

Review 8.  Spondyloarthritis in sub-Saharan Africa.

Authors:  Mohammed Tikly; Panganani Njobvu; Paul McGill
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

9.  Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals.

Authors:  R W Karr; Y Hahn; B D Schwartz
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

10.  Race-related differences in HLA association with ankylosing spondylitis and Reiter's disease in American blacks and whites.

Authors:  M A Khan
Journal:  J Natl Med Assoc       Date:  1978-01       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.